Northern Health

Epping VIC 3076

1 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia (AML), Diffuse Large B Cell Lymphoma (DLBCL), Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS), Primary Sclerosing Cholangitis, Relapsed or Refractory Multiple Myeloma (RRMM)

Studies at this site

• Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation — Recruiting now
• GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies — Stopped early
• A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) — Running, not enrolling